Q3 2019 Investor Presentation
Extending connected health solutions to COPD & asthma
Acquired Propeller Health in January 2019
Digital therapeutics company providing
connected health solutions for people with
COPD and asthma
Uses sensors with inhalers to track medication
usage and provide personal feedback and
insights
Establishes ResMed as a leading provider of
COPD and asthma patient management
solutions
Enables integration of care through the
progression of the disease.
UPSTREAM
Customers include:
gsk
Boehringer
Ingelheim
$$
Patients + $$
ORION
NOVARTIS
Increased drug
adherence and sales
Propeller
Pharma companies signed
represent 90% of long-acting
respiratory inhalation drugs
©2019 ResMed I Q3 2019 Investor Presentation | 22
Improved clinical trial
speed and enhanced
time to market
D
Patient Acquisition
+
Health and
economic outcomes
DOWNSTREAM
Payers
Anthem.
PBMs
EXPRESS SCRIPTS
Clinical insights
and efficiencies
Health
systems
Dignity Health
$$
Pharmacies Walgreens
Patients + $$
ResMedView entire presentation